Christopher Powala Insider Trading
Get free email notifications about insider trading for Christopher Powala.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Powala. Christopher Powala is a Chief Operating Officer in Aclaris Therapeutics, Inc. ($ACRS) and a Chief Reg & Develop Officer in Aclaris Therapeutics, Inc. ($ACRS).
Address: C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400 MALVERN 19355 PA
Companies in which Christopher Powala is an Insider
Aclaris Therapeutics, Inc.
Trading Symbol: ACRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Powala: Chief Reg & Develop Officer, Chief Operating Officer
Holdings: 142,843 shares
Current Value: $3,606,786
Latest Transaction: Feb 05 2019
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Christopher Powala
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 3,400 | 0 | 10,200 | |
Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 6.96 | 1,114 | 7,753 | 141,729 | 142.8 K to 141.7 K (-0.78 %) |
Feb 05 2019 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 3,400 | 0 | 142,843 | 139.4 K to 142.8 K (+2.44 %) |
Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,625 | 0 | 1,625 | |
Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 6.30 | 446 | 2,810 | 139,443 | 139.9 K to 139.4 K (-0.32 %) |
Dec 21 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 1,625 | 0 | 139,889 | 138.3 K to 139.9 K (+1.18 %) |
Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 1,300 | 0 | 2,600 |